Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

8.54
BATS BZX Real-Time Price
As of 2:36pm ET
 +0.07 / +0.83%
Today’s Change
3.70
Today|||52-Week Range
9.25
+49.30%
Year-to-Date

Today’s Trading

Previous close8.47
Today’s open8.44
Day’s range8.43 - 8.55
Volume2,803
Average volume (3 months)67,103
Market cap$191.3M
Dividend yield--
Data as of 2:36pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-11.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+33.56%
P/E ratioNM
Price/Sales5.42
Price/Book3.99

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...-0.02-0.42%
EGLTEgalet Corp-0.16-2.14%
SELBSelecta Biosciences ...+0.19+1.75%
AGRXAgile Therapeutics I...+0.13+1.92%
Data as of 2:22pm ET, 07/29/2016

Financials

Last reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$20.1M
Annual profit (last year)-$12.8M
Net profit margin-63.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs